Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada

Andrysiak, 2008, Genetic characterization of clinical and agri-food isolates of multi drug resistant Salmonella enterica serovar Heidelberg from Canada, BMC Microbiol, 8, 89, 10.1186/1471-2180-8-89 Baudry, 2009, Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units, Diagn. Microbiol. Infect. Dis., 65, 379, 10.1016/j.diagmicrobio.2009.08.011 Baudry, 2008, Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase–producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units, Antimicrob. Agents Chemother., 52, 1846, 10.1128/AAC.01176-07 Blanc, 2008, Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms, Int. J. Antimicrob. Agents, 31, 76, 10.1016/j.ijantimicag.2007.07.031 Carattoli, 2005, Identification of plasmids by PCR-based replicon typing, J. Microbiol. Methods, 63, 219, 10.1016/j.mimet.2005.03.018 Carattoli, 2006, Replicon typing of plasmids encoding resistance to newer beta-lactams, Emerging Infect. Dis., 12, 1145, 10.3201/eid1207.051555 Daniels, 2007, Molecular epidemiology of blaCMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest, Appl. Environ. Microbiol., 73, 8005, 10.1128/AEM.01325-07 Garcia-Fernandez, 2008, Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin, J. Antimicrob. Chemother., 61, 1229, 10.1093/jac/dkn131 Hopkins, 2006, Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates, Antimicrob. Agents Chemother., 50, 3203, 10.1128/AAC.00149-06 Jacoby, 2009, AmpC beta-lactamases, Clin. Microbiol. Rev, 22, 161, 10.1128/CMR.00036-08 Lindsey, 2009, Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates, Appl. Environ. Microbiol., 75, 1908, 10.1128/AEM.02228-08 Mataseje, 2009, Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006, Antimicrob. Agents Chemother., 53, 3126, 10.1128/AAC.01353-08 Mataseje, 2009, Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005–06, J. Antimicrob. Chemother., 64, 723, 10.1093/jac/dkp249 Mulvey, 2008, Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources, Vet. Microbiol., 134, 279, 10.1016/j.vetmic.2008.08.018 Mulvey, 2004, Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals, Antimicrob. Agents Chemother., 48, 1204, 10.1128/AAC.48.4.1204-1214.2004 Papanicolaou, 1990, Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino-and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae, Antimicrob. Agents Chemother., 34, 2200, 10.1128/AAC.34.11.2200 Pitout, 2008, Multiresistant Enterobacteriaceae: new threat of an old problem, Expert Rev. Anti Infect. Ther., 6, 657, 10.1586/14787210.6.5.657 Winokur, 2001, Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans, Antimicrob. Agents Chemother., 45, 2716, 10.1128/AAC.45.10.2716-2722.2001